Correlation Between Sinphar Pharmaceutical and Synmosa Biopharma
Can any of the company-specific risk be diversified away by investing in both Sinphar Pharmaceutical and Synmosa Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sinphar Pharmaceutical and Synmosa Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sinphar Pharmaceutical Co and Synmosa Biopharma, you can compare the effects of market volatilities on Sinphar Pharmaceutical and Synmosa Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sinphar Pharmaceutical with a short position of Synmosa Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sinphar Pharmaceutical and Synmosa Biopharma.
Diversification Opportunities for Sinphar Pharmaceutical and Synmosa Biopharma
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Sinphar and Synmosa is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Sinphar Pharmaceutical Co and Synmosa Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Synmosa Biopharma and Sinphar Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sinphar Pharmaceutical Co are associated (or correlated) with Synmosa Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Synmosa Biopharma has no effect on the direction of Sinphar Pharmaceutical i.e., Sinphar Pharmaceutical and Synmosa Biopharma go up and down completely randomly.
Pair Corralation between Sinphar Pharmaceutical and Synmosa Biopharma
Assuming the 90 days trading horizon Sinphar Pharmaceutical Co is expected to generate 0.8 times more return on investment than Synmosa Biopharma. However, Sinphar Pharmaceutical Co is 1.25 times less risky than Synmosa Biopharma. It trades about 0.13 of its potential returns per unit of risk. Synmosa Biopharma is currently generating about -0.13 per unit of risk. If you would invest 3,090 in Sinphar Pharmaceutical Co on November 30, 2024 and sell it today you would earn a total of 55.00 from holding Sinphar Pharmaceutical Co or generate 1.78% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 95.0% |
| Values | Daily Returns |
Sinphar Pharmaceutical Co vs. Synmosa Biopharma
Performance |
| Timeline |
| Sinphar Pharmaceutical |
| Synmosa Biopharma |
Sinphar Pharmaceutical and Synmosa Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sinphar Pharmaceutical and Synmosa Biopharma
The main advantage of trading using opposite Sinphar Pharmaceutical and Synmosa Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sinphar Pharmaceutical position performs unexpectedly, Synmosa Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Synmosa Biopharma will offset losses from the drop in Synmosa Biopharma's long position.| Sinphar Pharmaceutical vs. Abnova Taiwan Corp | Sinphar Pharmaceutical vs. YungShin Global Holding | Sinphar Pharmaceutical vs. Phytohealth Corp | Sinphar Pharmaceutical vs. Wellell |
| Synmosa Biopharma vs. U Media Communications | Synmosa Biopharma vs. Univacco Technology | Synmosa Biopharma vs. Kinsus Interconnect Technology | Synmosa Biopharma vs. China Mobile |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Stocks Directory Find actively traded stocks across global markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |